BioTelemetry,Inc. (NASDAQ:BEAT) Files An 8-K Financial Statements and Exhibits

BioTelemetry,Inc. (NASDAQ:BEAT) Files An 8-K Financial Statements and Exhibits
Item 9.01 of Form8-K, and this amendment should be read in conjunction with the Original 8-K. Except as set forth herein, no modifications have been made to information contained in the Original 8-K, and the Company has not updated any information contained therein to reflect events that have occurred since the date of the Original 8-K.

Story continues below

This Current Report on Form8-K/A amends the Original Filing to include the financial statements and pro forma information required by Item 9.01.

Item 9.01. Financial Statements and Exhibits

(a)Financial Statements of Business Acquired

The audited financial statements of LifeWatch for the years ended December31, 2016, 2015 and 2014 and the related notes and the unaudited financial statements of LifeWatch as of March31, 2017 and December31, 2016, and for the three months ended March31, 2017 and 2016 and the related notes are attached hereto as Exhibit99.1 and Exhibit99.2 and incorporated by reference into this Item 9.01.

(b)Pro-Forma Financial Information

Unaudited pro forma condensed combined financial information, which include a pro forma condensed combined balance sheet as of March31, 2017 and pro forma condensed combined statements of operations for the three months ended March31, 2017 and the year ended December31, 2016 and the notes related thereto, are filed as Exhibit99.3 to this report and incorporated herein by reference.

(d)List of Exhibits

EXHIBIT NO.

DESCRIPTION

23.1

Consent of independent auditors.

99.1

Audited financial statements of LifeWatch for the years ended December31, 2016, 2015 and 2014 and the related notes to such financial statements.

99.2

Unaudited financial statements of LifeWatch as of March31, 2017 and December31, 2016, and for the three months ended March31, 2017 and 2016 and the related notes to such financial statements.

99.3

Unaudited pro forma condensed combined financial statements, which include a pro forma condensed combined balance sheet as of March31, 2017 and pro forma condensed combined statements of operations for the year ended December31, 2016 and the three months ended March31, 2017.


BioTelemetry, Inc. Exhibit
EX-23.1 2 a17-22193_1ex23d1.htm EX-23.1 Exhibit 23.1   Consent of Independent Auditors   We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 No. 333-216189 and Forms S-8 No. 333-202280,…
To view the full exhibit click here

An ad to help with our costs